The anti-choice organization Center for Medical Progress—which, in 2013, claimed tax-exempt status as a biomedical charity—has recently released two “undercover” videos of Planned Parenthood officials discussing post-procedure tissue donation. The group claims the videos demonstrate that Planned Parenthood profits from fetal tissue donation (which would be illegal) and that they are “haggling” over the price of “baby parts.”

As an OB/GYN, I can tell you that neither of these claims are true.

These are not "baby parts." Whether a woman has a miscarriage or an abortion, the tissue specimen is called "products of conception." In utero, i.e. during pregnancy, we use the term "embryo" from fertilization to ten weeks gestation and "fetus" from ten weeks to birth. The term baby is medically incorrect as it doesn’t apply until birth. Calling the tissue “baby parts” is a calculated attempt to anthropomorphize an embryo or fetus. It is a false image—a ten to twelve week fetus looks nothing like a term baby—and is medically incorrect.

Hearing medical professionals talk casually about products of conception may seem distasteful to some, but not to doctors. Medical procedures are gory by nature. Surgeons routinely cut skin, saw bones, and lift the uterus out of the abdominal cavity and then put it back in. We stick our hands inside people and it is messy. We handle broken limbs, rotting flesh, and cancers that smell. We talk about this calmly because this is what we are trained to do. It doesn’t mean that we are heartless; it means we are professionals and this is our norm for a clinical conversation. There is no reason a conversation about products of conception requires more or less reverence than one about a kidney or a biopsy specimen.

Hearing medical professionals negotiate with a private buyer over the price for collecting tissue may also seem distasteful, but there is indeed an expense involved for the donor (in this case, Planned Parenthood). FactCheck.org contacted several researchers who work with human tissue, and the price range mentioned in the videos—$30 to $100 per patient—is on the low end. “There’s no way there’s a profit at that price,” Sherilyn J. Sawyer, the director of Harvard University and Brigham and Women’s Hospital’s Biorepository, told the website.